Bikramjit Das

Bikramjit Das

Active Director Director DIN 07069016
DIN 07069016 First appointment Jan 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2015
Shareholding value •••• Premium profile

About Bikramjit Das

Data last updated:

Bikramjit Das is a Director at Alienus Pharmaceutical Private Limited (since 2015). The company operates in Pharma. Alienus Pharmaceutical Private Limited reported revenue of ₹2.5 Lakh (FY 2019).

DIN 07069016
Primary Designation Director
Industry Pharma
First Appointment 30 Jan 2015
Oldest Company Age 11 yrs
Largest company Alienus Pharmaceutical Private Limited · ₹2.5 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jan 20152015₹2.5 Lakh (FY 2019)Active

Board colleagues of Bikramjit Das

NameDINCompanyDesignation
Soma Biswas07579607Alienus Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alienus Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Bikramjit Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bikramjit Das

Bikramjit Das currently holds 1 directorship: Alienus Pharmaceutical Private Limited (Director, since 30 Jan 2015, revenue ₹2.5 Lakh (FY 2019)).

Bikramjit Das was first appointed on 30 Jan 2015 as Director at Alienus Pharmaceutical Private Limited.

The current boards of Bikramjit Das's companies include Soma Biswas (Alienus Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available